Pediatric Medical Countermeasures Ethical Considerations Titelbild

Pediatric Medical Countermeasures Ethical Considerations

Pediatric Medical Countermeasures Ethical Considerations

Von: Presidential Commission for the Study of Bioethical Iss
Jetzt kostenlos hören, ohne Abo

Über diesen Titel

 Safeguarding Children Pediatric Medical Countermeasure Research responds to Health and Human Services Secretary Kathleen Sebeliuss call for an ethical examination of anthrax vaccine trials involving children. In January 2012, after a federal committee recommended initiating such research, the Bioethics Commission was tasked with investigating the ethical implications. Their findings emphasized that extensive adult testing is essential before any pediatric trials can ethically proceed. The Commission outlined rigorous conditions that must be satisfied before considering research on pediatric medical countermeasures (MCM), which encompass federally-regulated drugs and products used in response to chemical, biological, radiological, and nuclear threats. This report not only addresses the specific case of anthrax but also delves into broader ethical concerns surrounding pediatric research in the realm of medical countermeasures.Copyright Early Modern Hygiene & gesundes Leben Politik & Regierungen Sozialwissenschaften Wissenschaft
Folgen
  • 008 - Chapter 3 Ethical Considerations for Pediatric Medical Countermeasure Research - part 4

    008 - Chapter 3 Ethical Considerations for Pediatric Medical Countermeasure Research - part 4
    Mar 3 2026
    Safeguarding Children Pediatric Medical Countermeasure Research responds to Health and Human Services Secretary Kathleen Sebeliuss call for an ethical examination of anthrax vaccine trials involving children. In January 2012, after a federal committee recommended initiating such research, the Bioethics Commission was tasked with investigating the ethical implications. Their findings emphasized that extensive adult testing is essential before any pediatric trials can ethically proceed. The Commission outlined rigorous conditions that must be satisfied before considering research on pediatric medical countermeasures (MCM), which encompass federally-regulated drugs and products used in response to chemical, biological, radiological, and nuclear threats. This report not only addresses the specific case of anthrax but also delves into broader ethical concerns surrounding pediatric research in the realm of medical countermeasures.
    Mehr anzeigen Weniger anzeigen
    35 Min.
Noch keine Rezensionen vorhanden